Medication info
Genuwon Olmesartan Tablet 10 mg (Olmesartan Medoxomil)

Genuwon Olmesartan Tablet 10 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›10mg / 1 tablet
Manufacturer / importer
Genuwon Science Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201400392 · Approved 2014.01.28 · Insurance code 671704140

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time every day (e.g., in the morning), if possible. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is required when administering this medicine to patients aged 65 years or older. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. As there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
Safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Genuwon Science Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is treated to control blood pressure to a normal range, reducing the risk of cardiovascular diseases and maintaining the health of the heart and blood vessels. This medication helps lower blood pressure to prevent complications arising from hypertension and to improve the overall quality of life for patients. Therefore, it is used for essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time every day (e.g., in the morning), if possible. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is required when administering this medicine to patients aged 65 years or older. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. As there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

Safety and efficacy in pediatric patients have not been established.

Precautions

This medication should not be used in women during the second and third trimesters of pregnancy, as it can cause serious harm or death to the fetus and newborn; therefore, treatment should be discontinued immediately upon confirmation of pregnancy. Do not use this medication in patients allergic to its ingredients, pregnant or nursing women, patients undergoing kidney dialysis, patients with severe liver dysfunction, patients with biliary obstruction, and patients with lactose intolerance. In patients with decreased blood volume or low salt levels, hypotension may occur, so it is important to check their condition carefully before starting treatment and take appropriate measures if hypotension occurs. For patients with impaired kidney function or kidney transplant recipients, there may be changes in kidney function when taking this medication, so regular blood testing to monitor kidney function and electrolyte levels is required. Due to the risk of hyperkalemia, patients with heart failure or kidney disorders should carefully monitor their potassium levels. Patients with aortic stenosis, mitral valve stenosis, or obstructive cardiomyopathy may experience worsening symptoms due to the blood pressure-lowering effects of this medication, so caution is necessary. Dizziness can occur when taking this medication, so avoid engaging in hazardous activities such as working from heights or driving. This medication may cause various side effects, including dizziness, headache, abdominal pain, diarrhea, muscle pain, rash, etc., but most are mild and temporary. If chronic diarrhea or weight loss occurs, consider the possibility of chronic malabsorption related to this medication and review the need to discontinue use. Caution is needed when taking with other antihypertensive medications, potassium-sparing diuretics, and potassium supplementation, as blood potassium levels may increase. When used with lithium, lithium levels can increase, leading to toxicity, so it is advisable not to use them together. Caution is also required when using non-steroidal anti-inflammatory drugs, as it may worsen kidney function. Taking this medication during pregnancy may result in severe abnormalities in the fetus; therefore, if pregnancy is confirmed, discontinue use immediately. It is recommended that nursing mothers either discontinue breastfeeding or stop this medication as it may be passed into breast milk. Safety and efficacy in pediatric patients have not been established, so it is advisable not to use this medication in children. For the elderly, the body concentration of this medication may increase; therefore, careful observation and dosage adjustment may be necessary. In cases of overdose, hypotension and palpitations may occur, and appropriate treatment should be administered based on the symptoms.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • flu-like symptoms
Show 38 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial swelling
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • increased serum creatinine
  • hair loss
  • pruritus
  • hives
  • autoimmune hepatitis
  • headache
  • hypertension
  • nosebleed
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is room temperature between 1 to 25 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.